Kin Yin Cheung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kin Yin Cheung has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Bin Yang
Medical Physics and Research Department, Hong Kong Sanatorium & Hospital, 2 Village Road, Happy Valley, Hong Kong
3 shared publications - Siu Ki Yu
Medical Physics and Research Department, Hong Kong Sanatorium & Hospital, 8/F, Li Shu Fan Block, Hong Kong Sanatorium & Hospital 2 Village Road, Happy Valley, Hong Kong, N/A, HONG KONG
3 shared publications - Jing Yuan
Medical Physics and Research Department, Hong Kong Sanatorium & Hospital, Hong Kong, China
2 shared publications - C W Kong
Medical Physics Department, Hong Kong Sanatorium & Hospital, 2 Village Road, Happy Valley, Hong Kong SAR, China
1 shared publication - Chen-Yu Huang
Medical Physics Department, Hong Kong Sanatorium and Hospital, Hong Kong, China
1 shared publication - Chin Chak Ho
National Yunlin University of Science and Technology
1 shared publication
Latest Publications
- 26 December 2022
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 89 (5) , 2088-2099
A pilot study of MRI radiomics for high‐risk prostate cancer stratification in 1.5 T MR‐guided radiotherapy
Purpose: To investigate the potential value of MRI radiomics obtained from a 1.5 T MRI‐guided linear accelerator (MR‐LINAC) for D'Amico high‐risk prostate cancer (PC) classification in MR‐guided radiotherapy (MRgRT).Methods: One hundred seventy‐six consecutive PC patients underwent 1.5 T MRgRT treatment were retrospectively enrolled. Each patient received one or two pretreatment T2‐weighted MRI scans on a 1.5 T MR‐LINAC. The endpoint was to differentiate high‐risk from low/intermediate‐risk PC based on D'Amico criteria using MRI‐radiomics. Totally 1023 features were extracted from clinical target volume (CTV) and planning target volume (PTV). Intraclass correlation coefficient of scan–rescan repeatability, feature correlation, and recursive feature elimination were used for feature dimension reduction. Least absolute shrinkage and selection operator regression was employed for model construction. Receiver operating characteristic area under the curve (AUC) analysis was used for model performance assessment in both training and testing data.Results: One hundred and eleven patients fulfilled all criteria were finally included: 76 for training and 35 for testing. The constructed MRI‐radiomics models extracted from CTV and PTV achieved the AUC of 0.812 and 0.867 in the training data, without significant difference (P = 0.083). The model performances remained in the testing. The sensitivity, specificity, and accuracy were 85.71%, 64.29%, and 77.14% for the PTV‐based model; and 71.43%, 71.43%, and 71.43% for the CTV‐based model. The corresponding AUCs were 0.718 and 0.750 (P = 0.091) for CTV‐ and PTV‐based models.Conclusion: MRI‐radiomics obtained from a 1.5 T MR‐LINAC showed promising results in D'Amico high‐risk PC stratification, potentially helpful for the future PC MRgRT. Prospective studies with larger sample sizes and external validation are warranted for further verification.
- 26 December 2022
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 89 (5) , 2088-2099
A pilot study of MRI radiomics for high‐risk prostate cancer stratification in 1.5 T MR‐guided radiotherapy
Purpose: To investigate the potential value of MRI radiomics obtained from a 1.5 T MRI‐guided linear accelerator (MR‐LINAC) for D'Amico high‐risk prostate cancer (PC) classification in MR‐guided radiotherapy (MRgRT).Methods: One hundred seventy‐six consecutive PC patients underwent 1.5 T MRgRT treatment were retrospectively enrolled. Each patient received one or two pretreatment T2‐weighted MRI scans on a 1.5 T MR‐LINAC. The endpoint was to differentiate high‐risk from low/intermediate‐risk PC based on D'Amico criteria using MRI‐radiomics. Totally 1023 features were extracted from clinical target volume (CTV) and planning target volume (PTV). Intraclass correlation coefficient of scan–rescan repeatability, feature correlation, and recursive feature elimination were used for feature dimension reduction. Least absolute shrinkage and selection operator regression was employed for model construction. Receiver operating characteristic area under the curve (AUC) analysis was used for model performance assessment in both training and testing data.Results: One hundred and eleven patients fulfilled all criteria were finally included: 76 for training and 35 for testing. The constructed MRI‐radiomics models extracted from CTV and PTV achieved the AUC of 0.812 and 0.867 in the training data, without significant difference (P = 0.083). The model performances remained in the testing. The sensitivity, specificity, and accuracy were 85.71%, 64.29%, and 77.14% for the PTV‐based model; and 71.43%, 71.43%, and 71.43% for the CTV‐based model. The corresponding AUCs were 0.718 and 0.750 (P = 0.091) for CTV‐ and PTV‐based models.Conclusion: MRI‐radiomics obtained from a 1.5 T MR‐LINAC showed promising results in D'Amico high‐risk PC stratification, potentially helpful for the future PC MRgRT. Prospective studies with larger sample sizes and external validation are warranted for further verification.
- 30 April 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (3) , 035022
Initial clinical experience of patient-specific QA of treatment delivery in online adaptive radiotherapy using a 1.5 T MR-Linac
Purpose . This study aims to evaluate the performance of a commercial 1.5 T MR-Linac by analyzing its patient-specific quality assurance (QA) data collected during one full year of clinical operation. Methods and Materials . The patient-specific QA system consisted of offline delivery QA (DQA) and online calculation-based QA. Offline DQA was based on ArcCHECK-MR combined with an ionization chamber. Online QA was performed using RadCalc that calculated and compared the point dose calculation with the treatment planning system (TPS). A total of 24 patients with 189 treatment fractions were enrolled in this study. Gamma analysis was performed and the threshold that encompassed 95% of QA results (T95) was reported. The plan complexity metric was calculated for each plan and compared with the dose measurements to determine whether any correlation existed. Results . All point dose measurements were within 5% deviation. The mean gamma passing rates of the group data were found to be 96.8 ± 4.0% and 99.6 ± 0.7% with criteria of 2%/2mm and 3%/3mm, respectively. T95 of 87.4% and 98.2% was reported for the overall group with the two passing criteria, respectively. No statistically significant difference was found between adaptive treatments with adapt-to-position (ATP) and adapt-to-shape (ATS), whilst the category of pelvis data showed a better passing rate than other sites. Online QA gave a mean deviation of 0.2 ± 2.2%. The plan complexity metric was positively correlated with the mean dose difference whilst the complexity of the ATS cohort had larger variations than the ATP cohort. Conclusions . A patient-specific QA system based on ArcCHECK-MR, solid phantom and ionization chamber has been well established and implemented for validation of treatment delivery of a 1.5 T MR-Linac. Our QA data obtained over one year confirms that good agreement between TPS calculation and treatment delivery was achieved.
- 30 April 2021
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 7 (3) , 035022
Initial clinical experience of patient-specific QA of treatment delivery in online adaptive radiotherapy using a 1.5 T MR-Linac
Purpose . This study aims to evaluate the performance of a commercial 1.5 T MR-Linac by analyzing its patient-specific quality assurance (QA) data collected during one full year of clinical operation. Methods and Materials . The patient-specific QA system consisted of offline delivery QA (DQA) and online calculation-based QA. Offline DQA was based on ArcCHECK-MR combined with an ionization chamber. Online QA was performed using RadCalc that calculated and compared the point dose calculation with the treatment planning system (TPS). A total of 24 patients with 189 treatment fractions were enrolled in this study. Gamma analysis was performed and the threshold that encompassed 95% of QA results (T95) was reported. The plan complexity metric was calculated for each plan and compared with the dose measurements to determine whether any correlation existed. Results . All point dose measurements were within 5% deviation. The mean gamma passing rates of the group data were found to be 96.8 ± 4.0% and 99.6 ± 0.7% with criteria of 2%/2mm and 3%/3mm, respectively. T95 of 87.4% and 98.2% was reported for the overall group with the two passing criteria, respectively. No statistically significant difference was found between adaptive treatments with adapt-to-position (ATP) and adapt-to-shape (ATS), whilst the category of pelvis data showed a better passing rate than other sites. Online QA gave a mean deviation of 0.2 ± 2.2%. The plan complexity metric was positively correlated with the mean dose difference whilst the complexity of the ATS cohort had larger variations than the ATP cohort. Conclusions . A patient-specific QA system based on ArcCHECK-MR, solid phantom and ionization chamber has been well established and implemented for validation of treatment delivery of a 1.5 T MR-Linac. Our QA data obtained over one year confirms that good agreement between TPS calculation and treatment delivery was achieved.
- 1 December 2016
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 2 (6) , 067003
Dose rate versus gantry speed test in RapidArc commissioning: a feasibility study using ArcCHECK
The present study was to investigate the feasibility of using ArcCHECK for dose rate versus gantry speed test in RapidArc commissioning. Current test methods using film or electronic portal imaging device could not provide information about dose rate, gantry speed and actual gantry angle at each control point. The technique proposed aimed to directly measure those parameter variations during plan delivery. The device was isocentrically set up and programmed to record the detector signal and gantry angle every 50 ms as a movie file. A plan with variable gantry speed ranging from 1° s–1 to 6° s–1 was designed for testing the accuracy of measured gantry speed without dose rate modulation. A dose rate versus gantry speed test was designed for testing some extreme machine settings. The processed data of gantry angle had a mean deviation of 0.01° from the machine log data. Linear regression was applied to the processed angle versus time data to obtain an averaged gantry speed between control points. The uncertainty of calculated gantry speed was found to be within 1% for plans with or without dose rate modulation. The mean deviation of measured dose rate was 0.01%, with range of −0.58% to 0.56%. The deviation of characteristic parameter MU/degree for the dose rate versus gantry speed plan ranged from −0.70% to 0.60%. The actual gantry angle at each control point was calculated to have a difference within 0.5° when compared with the plan setting. Our proposed method can measure the dose rate, gantry speed and actual gantry angle at each control point directly and accurately.
- 1 December 2016
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 2 (6) , 067003
Dose rate versus gantry speed test in RapidArc commissioning: a feasibility study using ArcCHECK
The present study was to investigate the feasibility of using ArcCHECK for dose rate versus gantry speed test in RapidArc commissioning. Current test methods using film or electronic portal imaging device could not provide information about dose rate, gantry speed and actual gantry angle at each control point. The technique proposed aimed to directly measure those parameter variations during plan delivery. The device was isocentrically set up and programmed to record the detector signal and gantry angle every 50 ms as a movie file. A plan with variable gantry speed ranging from 1° s–1 to 6° s–1 was designed for testing the accuracy of measured gantry speed without dose rate modulation. A dose rate versus gantry speed test was designed for testing some extreme machine settings. The processed data of gantry angle had a mean deviation of 0.01° from the machine log data. Linear regression was applied to the processed angle versus time data to obtain an averaged gantry speed between control points. The uncertainty of calculated gantry speed was found to be within 1% for plans with or without dose rate modulation. The mean deviation of measured dose rate was 0.01%, with range of −0.58% to 0.56%. The deviation of characteristic parameter MU/degree for the dose rate versus gantry speed plan ranged from −0.70% to 0.60%. The actual gantry angle at each control point was calculated to have a difference within 0.5° when compared with the plan setting. Our proposed method can measure the dose rate, gantry speed and actual gantry angle at each control point directly and accurately.
- Open Access
- 1 October 2016
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 96 (2) , E609
Delineation Variability of Head and Neck Organs at Risk on T1-Weighted Isotropic Magnetic Resonance Images: A Pilot Study on Healthy Volunteers
- 1 October 2016
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 96 (2) , E609
Open AccessDelineation Variability of Head and Neck Organs at Risk on T1-Weighted Isotropic Magnetic Resonance Images: A Pilot Study on Healthy Volunteers
- 1 January 2009
- Published by Springer Nature
- p. 628-630
Dosimetric Errors of TPS Calculations without Correction for Heterogeneity - A Study Using CIRS Thorax Phantom
- 1 January 2009
- Published by Springer Nature
- p. 628-630
Dosimetric Errors of TPS Calculations without Correction for Heterogeneity - A Study Using CIRS Thorax Phantom